Invea Therapeutics Appoints Mr. Jason Fenton to Its Board of Directors
– Mr. Fenton augments board expertise as the Company readies for Phase 1b/2 execution of lead program targeting mast cell biology
– Company also primed to advance additional programs, including a pan-inflammasome inhibitor
